1028212

Rigel Pharmaceuticals Inc — FEI 3004865166

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
South San Francisco, CA (United States)

Additional Details

Sponsor, Contract Research Organization